RESEARCH PROTOCOL: Glaucoma Treatment Adherence and Persistence
NCT ID: NCT01409421
Last Updated: 2015-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
201 participants
INTERVENTIONAL
2011-04-30
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening and Intervention for Glaucoma and Eye Health Through Telemedicine
NCT04274764
Improving Access to Eye Care in Glaucoma Patients
NCT02982629
Acceptance and Commitment Therapy Delivered by Automated Software Messaging
NCT04329897
Project inCharge: Increasing the Rate of Comprehensive Eye Care Utilization by Older African Americans Through Community-Based Eye Health Education Program
NCT00591110
Effectiveness of Home-Based Health Messaging for Patients With Hypertension and Diabetes
NCT00119054
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
motivational interviewing
3 phone and 3 in person counseling support sessions with glaucoma educator
motivational interviewing
counseling intervention
reminder calls
behavioral: three phone calls to remind patients to take their eye drops
three phone calls to remind patients to take their eye drops
reminder phone calls
standard care
standard care for glaucoma
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
motivational interviewing
counseling intervention
three phone calls to remind patients to take their eye drops
reminder phone calls
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* a current prescription for monotherapy topical glaucoma medication.
Exclusion Criteria
* cognitive impairment at a level that would in the judgment of the referring physician interfere with study participation,
* referring physician's determination that glaucoma surgery is likely within the next 6 months,
* any active medical, psychological, or substance use disorder that would in the referring physician's judgment significantly interfere with study participation (e.g., comorbid congestive heart failure (CHF) resulting in a recent hospitalization; active psychosis due to uncontrolled bipolar disorder; etc.), or
* no visual field test within the past 6 months (data required for the randomization approach described below).
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Merck Sharp & Dohme LLC
INDUSTRY
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Malik Kahook, MD
Role: PRINCIPAL_INVESTIGATOR
Lions Eye Inst. UC Denver
Paul F Cook, Ph.D
Role: PRINCIPAL_INVESTIGATOR
UC Denver, College of Nursing
Jeffery Kammer, MD
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt University- Opthamology
Steve Mansberger, MD
Role: PRINCIPAL_INVESTIGATOR
Devers Eye Inst. Oregon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lions Eye Institute, UC Denver
Aurora, Colorado, United States
Devers Eye Institute
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cook PF, Schmiege SJ, Mansberger SL, Kammer J, Fitzgerald T, Kahook MY. Predictors of adherence to glaucoma treatment in a multisite study. Ann Behav Med. 2015 Feb;49(1):29-39. doi: 10.1007/s12160-014-9641-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2517807
Identifier Type: OTHER
Identifier Source: secondary_id
11-0122
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.